131 related articles for article (PubMed ID: 1967969)
1. Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies.
Ashby CR; Wang RY
Brain Res; 1990 Jan; 506(2):346-8. PubMed ID: 1967969
[TBL] [Abstract][Full Text] [Related]
2. Effects of (+/-)-DOI on medial prefrontal cortical cells: a microiontophoretic study.
Ashby CR; Edwards E; Harkins K; Wang RY
Brain Res; 1989 Oct; 498(2):393-6. PubMed ID: 2790491
[TBL] [Abstract][Full Text] [Related]
3. Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity.
Rasmussen K; Aghajanian GK
Neuropsychopharmacology; 1988 May; 1(2):101-7. PubMed ID: 2908015
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
5. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
Bergqvist PB; Dong J; Blier P
Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Ashby CR; Jiang LH; Kasser RJ; Wang RY
J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
[TBL] [Abstract][Full Text] [Related]
7. Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic study.
Gobbi G; Janiri L
Eur Neuropsychopharmacol; 1999 Dec; 10(1):43-9. PubMed ID: 10647096
[TBL] [Abstract][Full Text] [Related]
8. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
Deutch AY; Duman RS
Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
Hand TH; Hu XT; Wang RY
Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
[TBL] [Abstract][Full Text] [Related]
10. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
Ashby CR; Edwards E; Wang RY
Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
[TBL] [Abstract][Full Text] [Related]
11. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
Matsubara S; Meltzer HY
Life Sci; 1989; 45(15):1397-406. PubMed ID: 2571912
[TBL] [Abstract][Full Text] [Related]
12. The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin.
Edwards E; Ashby CR; Wang RY
Brain Res; 1991 Apr; 545(1-2):276-8. PubMed ID: 1677603
[TBL] [Abstract][Full Text] [Related]
13. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.
Celada P; Puig MV; Díaz-Mataix L; Artigas F
Biol Psychiatry; 2008 Sep; 64(5):392-400. PubMed ID: 18436196
[TBL] [Abstract][Full Text] [Related]
14. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
[TBL] [Abstract][Full Text] [Related]
15. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat.
Ashby CR; Minabe Y; Edwards E; Wang RY
Synapse; 1991 Jul; 8(3):155-61. PubMed ID: 1683017
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
[TBL] [Abstract][Full Text] [Related]
19. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Matsubara R
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Aulakh CS; Hill JL; Yoney HT; Murphy DL
Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
